TAIEquity · Weekly research terminal

6919

CALIWAY BIOPHARMACEUTICALS CO L

TW Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
105.00 TWD
Fair value
86.77 TWD
Next-week expectancy
Undecided 51.19%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

6919

CALIWAY BIOPHARMACEUTICALS CO L

Healthcare Biotechnology

Caliway Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the development of drugs for aesthetic medicine and chronic inflammation. The company develops CBL-514, an investigational drug, which is in Phase 2 clinical trial for non-surgical fat reduction and Dercum's disease, as well as for cellulite treatment. It is also developing CBA-539, which is in preclinical stage for central obesity, hyperpigmentation, and skin aging, as well as offers dietary supplements. The company …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
161,864,548,352
Fair value reference
86.77
Next-week expectancy
Undecided · 51.19%

Over the latest 12 completed weeks ending 2026-08-07, 6919 rose 0.96%, moving from 104.00 to 105.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -47.20 and has improved across the 12-week window. Market Dynamics is 0.28 on the latest week. Next-week expectancy is undecided at 51.19% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
105.00
12-Week Change
0.96%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 51.19%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
105.00
12-Week Change
0.96%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 51.19%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-47.20
Market Dynamics
0.28

Over the latest 12 completed weeks ending 2026-08-07, 6919 rose 0.96%, moving from 104.00 to 105.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -47.20 and has improved across the 12-week window. Market Dynamics is 0.28 on the latest week. Next-week expectancy is undecided at 51.19% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6949 Pell Bio-Med Technology Co., Ltd. TAI 7 Aug 2026 800.00 999.00 799.00 943.00 17.88%
1762 Chunghwa Chemical Synthesis & Biotech Co., Ltd. TAI 7 Aug 2026 32.20 35.75 31.60 35.75 11.02%
6589 EirGenix Inc. TAI 7 Aug 2026 44.60 48.90 44.30 48.20 8.07%
7827 HanchorBio Inc. TAI 7 Aug 2026 144.50 157.50 144.50 156.00 7.96%
4142 Adimmune Corporation TAI 7 Aug 2026 16.55 17.80 16.45 17.70 6.95%
4178 StemCyte International, Ltd. TAI 7 Aug 2026 17.40 19.00 17.40 18.40 5.75%
6541 Tanvex BioPharma, Inc. TAI 7 Aug 2026 37.10 38.45 36.60 38.05 2.56%
6657 Energenesis Biomedical CO.,LTD. TAI 7 Aug 2026 30.50 31.55 29.40 31.20 2.30%
1733 Apex Biotechnology Corp. TAI 7 Aug 2026 31.30 33.10 30.80 32.00 2.24%
4133 Abnova (Taiwan) Corporation TAI 7 Aug 2026 20.75 21.85 20.75 21.20 2.17%
3164 GenMont Biotech Incorporation TAI 7 Aug 2026 16.25 16.60 16.00 16.40 0.92%
6885 BRIM Biotechnology, Inc. TAI 7 Aug 2026 20.95 21.20 20.50 21.10 0.72%
6550 Polaris Group TAI 7 Aug 2026 11.05 11.35 10.90 11.10 0.45%
1734 Sinphar Pharmaceutical Co.,Ltd. TAI 7 Aug 2026 31.70 31.80 31.30 31.80 0.32%
4169 TCM Biotech International Corp. TAI 7 Aug 2026 158.00 167.50 153.00 157.00 -0.63%
6838 Formosa Pharmaceuticals, Inc. TAI 7 Aug 2026 23.40 23.75 22.80 23.20 -0.85%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context